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Assessment of cardiac function continues to be an
important issue in patients with assumed left ventric-
ular dysfunction [1–10]. In particular in patients with
enlarged left ventricles, such as occurs in ischemic
and idiopathic dilated cardiomyopathy, accurate
assessment of left ventricular function remains piv-
otal [11–14]. To assess myocardial function, different
diagnostic methods are currently performed, such as
MRI, SPECT, and echocardiography [15–23]. In the
clinical arena, detection of myocardial function is
predominantly based on echocardiographic studies.
However, nuclear techniques, showing preserved
tracer uptake and metabolism in viable myocardium,
may also assess left ventricular function and wall
motion. Analysis by gated SPECT imaging offers
considerable additional value to SPECT myocardial
perfusion imaging in characterizing functional abnor-
malities thereby potentially improving test speciﬁcity
[24–30]. Preserved wall motion and/or thickening in
region with perfusion defects might denote remaining
viability indicating potentially well functioning myo-
cardium [31–36]. By assessing left ventricular
volumes the application of gated SPECT inﬂuences
the appropriate management strategy. Since myocar-
dial perfusion, function and wall motion/thickening
can be assessed simultaneously, gated SPECT imag-
ing follows the concept of a one-stop shop such as
propagated by MRI studies [37–41]. However, MRI
may be more accurate than gated SPECT in estab-
lishing left ventricular parameters because of its
superb spatial resolution [20, 42–49].
In the current issue of the International Journal of
Cardiovascular Imaging, Sipola et al. [50] prospec-
tively compared left ventricular end-diastolic volume
(EDV), end-systolic volume (ESV), and ejection
fraction (LVEF) both by gated SPECT and cardiac
MRI in 21 patients with idiopathic dilated cardiomy-
opathy. All 21 patients underwent both 99 mTc-
tetrofosmin gated SPECT imaging and MRI within a
3 h interval. Close linear correlations were observed
between both methods in left ventricular EDV and
left ventricular ESV but correlations were signiﬁ-
cantly weaker for LVEF. Left ventricular EDV and
left ventricular ESV were smaller for gated SPECT
than for MRI. In 4 patients (21%) the left ventricular
EDV index was considered normal by gated SPECT
and increased by MRI, if MRI-derived normal values
were used. No differences were found between gated
SPECT and MRI when MRI-determined LVEF was
below 40%. However, gated SPECT showed smaller
LVEF when MRI-determined LVEF was over 40%.
The authors concluded that an increased left ventric-
ular EDV in gated SPECT is reliable compared with
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DOI 10.1007/s10554-010-9717-xMRI. Nevertheless, left ventricular volumes were
systematically underestimated by gated SPECT and
underestimation was higher in patients with dilated
left ventricles. No direct comparisons could be made
between the two methods in follow-up studies. Based
on these ﬁndings [50], the authors suggest that
abnormal gated SPECT results should be conﬁrmed
by other imaging modalities, such as MRI, if these
ﬁndings have therapeutic consequences.
In comparing gated SPECT data with data from
established imaging techniques, inconsistent results
have been reported. Atsma et al. [51] compared
technetium-99 m tetrofosmin gated SPECT imaging
and contrast ventriculography in the assessment of
global and regional left ventricular function in 74
patients with undiagnosed chest pain of whom 27
sustained a previous myocardial infarction. The
authors reported that gated SPECT imaging is an
accurate and reliable clinical tool to accurately
measure global and regional left ventricular function.
Bavelaar-Croon et al. [52] compared results from
quantitative gated SPECT with results from MRI in
the assessment of left ventricular EDV, ESV, and
LVEF. Between the two methods, correlations were
good for LVEF (r = 0.85), EDV (r = 0.94), ESV
(r = 0.95). Wahba et al. [53] showed that gated
SPECT imaging when compared to MRI is a reliable
tool for the assessment of regional wall motion and
thickening in patients with known or suspected
coronary artery disease. In particular in patients with
a previously sustained myocardial infarction gated
SPECT imaging has the potential to detect preserved
wall motion and thickening in regions with ﬁxed
perfusion defects indicating the potential presence of
residual myocardial viability. Bax et al. [54] showed
close and signiﬁcant correlations for assessment of
left ventricular volumes, and regional wall motion by
MRI and gated SPECT in patients with ischemic
cardiomyopathy.
On the other hand, in a meta-analysis including
nine studies, Ioannidis and coworkers [55] demon-
strated that gated SPECT measurements of left
ventricular EDV, ESV and LVEF showed indeed
high correlation with cardiac MRI measurements, but
substantial errors may occur in individual patients.
Persson et al. [56] reported in 55 patients with known
or suspected coronary artery disease that gated
SPECT, compared with MRI, systematically under-
estimated EDV, ESV and LVEF. This phenomenon
might be due to the inclusion of the outﬂow tract area
by MRI, which is not part of left ventricular volume
acquisition with gated SPECT because of low counts
in this area. This holds in particular for dilated left
ventricles as the basal left ventricle constitutes a
higher absolute volume than in patients without left
ventricular dilatation. As already noticed by Sipola
et al. [50] the study by Wang et al. [57] showed that
the correlation between gated SPECT and cardiac
MRI was excellent for LV volume and LVEF values
in patients with idiopathic dilated cardiomyopathy.
However, algorithm-varying over- or underestimation
of left ventricular volumes and LVEF should be
accounted for in the clinical context.
To summarize, the current study by Sipola et al.
[50] clearly demonstrates that gated SPECT offers
useful and reliable functional information on left
ventricular function, which makes it suitable for
follow-up studies and guiding clinical management.
However, when accurate measurements of cardiac
volumes are required cardiac MRI should be used.
This holds in particular for patients with dilated
cardiomyopathy.
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